Search for: "D&B VENTURES, LLC" Results 261 - 280 of 309
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Jan 2011, 2:55 pm by Bexis
Dec. 9, 2008), rev’d, ___ F.3d ___, 2010 WL 5186062 (7th Cir. [read post]
5 Mar 2009, 4:00 am
(Peter Zura's 271 Patent Blog) (Patently-O) (Patent Prospector) (Patent Docs) (Patent Baristas) (Intellectual Property Watch) (Law360) (BLOG@IP::JUR) (Chicago Intellectual Property Law Blog) (Patently-O) (Inventive Step) (Washington State Patent Law Blog) (Techdirt) (Hal Wegner) Reactions to Patent Reform Bill 2009 (IP Watchdog) (Patent Baristas) (IP Watchdog) (IP Watchdog) (Patently-O) Worries about our patent system (The Invent Blog)   US Patents Licensing Executives Society urges… [read post]
3 Apr 2009, 3:49 am
EEO/iNewsSource: iNews Related to Equal Employment Opportunity - © 2009 John D. [read post]
22 Feb 2020, 4:12 am by Chris Wesner
” Tagnetics sought a stay pending appeal from this court, which the court denied through an order entered on November 15, 2019 (doc. 2 Liquidity event is defined as follows: (a) when one person or entity directly or indirectly becomes the beneficial owner of more than 50% of the outstanding securities of Tagnetics, provided that the one person or entity does not directly or indirectly own more than 50% of the outstanding securities of Tagnetics on the date that the agreement becomes… [read post]
14 Jan 2024, 8:10 am by Andrew Delaney
In re Apple Hill Solar LLC, 2023 VT 57 (Apple Hill III). [read post]
4 May 2019, 12:39 pm by MOTP
We noted that that the appellant "provide[d] no authority for her assertion that the Trust was required to support its claim with calculations supporting each month's interest computation over the life of the loan. [read post]
29 Jul 2013, 7:45 am by Schachtman
Elan Corporation[19], the Second Circuit affirmed the dismissal of a securities fraud class action against two pharmaceutical joint venturers, which issued a challenged press release on interim phase II clinical trial results for bapineuzumab, a drug for mild- to moderate-Alzheimer’s disease. [read post]
29 Apr 2020, 6:03 am by Chris Wesner
P. 8019(b)(3). 1 Tagnetics appeals the Bankruptcy Court’s October 25, 2019 “Order Granting in Part Tagnetics’ Motion to Enforce Settlement Agreement (Doc. 101) and Ordering Other Matters” (the “October 25 Order”). [read post]
28 Jan 2023, 7:32 am
  The state, then, in a markets privileging environment is caught on the horns of potentially incompatible objectives: the convergence of economic and administrative collectives around notions of compliance and state duty; or the promotion of risk taking in economic ventures to create prosperity and enhance the production of value that can then be tapped for all kinds of purposes. [read post]
29 Mar 2013, 2:00 pm by Bexis
 More specifically, the Restatement (Third) of Torts: Products Liability, § 2(b) states, in pertinent part, that a product is defective in design when the foreseeable risks of harm posed by the product could have been reduced or avoided by the adoption of a reasonable alternative design by the seller or other distributor, or a predecessor in the commercial chain of distribution, and that the omission of the alternative design renders the product not reasonably safe. [read post]
18 Dec 2014, 9:17 am by Robert B. Milligan and Michael Wexler
Throughout 2014, Seyfarth Shaw LLP’s dedicated Trade Secrets, Computer Fraud & Non-Competes Practice Group hosted a series of CLE webinars that addressed significant issues facing clients today in this important and ever changing area of law. [read post]